Strolll Secures €5M for AR Neurorehab
Strolll secured €5M to expand augmented-reality rehabilitation software for neurological disorders.
Augmented reality in healthcare is strongest when it solves a real capacity problem, not when it just looks futuristic.
What happened
UK medtech company Strolll secured €5M through Innovate UK-backed financing and additional investment. The company builds augmented-reality rehabilitation software for neurological disorders.
Its tools support assessment and therapy workflows, including bedside rehabilitation. The aim is to help clinicians deliver more consistent neurorehabilitation while collecting useful patient-progress data.
Why it matters
Neurological rehabilitation is labour-intensive, repetitive and often capacity-constrained. Patients may need frequent guided exercises, while clinicians have limited time and resources.
Strolll’s product sits at the intersection of AR, clinical workflow and digital therapeutics. The important question is not whether AR can create an impressive demo, but whether it can improve therapy consistency, patient engagement and clinician productivity in real care settings.
The bigger picture
Healthtech investors are still interested in tools that expand clinical capacity. The strongest digital-health products increasingly look like workflow infrastructure: they help clinicians do more with constrained teams while keeping the patient experience structured and measurable.